Fintech firm Cashfree Payments' co-founder Reeju Datta says cross-border segment is the fastest-growing, and operates on a higher margin than domestic transactions
Vedanta approaches the Madras High Court after TNPCB rejects its proposal to set up a Green Copper plant at the closed Sterlite unit in Thoothukudi
The government's stake sale in BHEL was over-subscribed two times on the first day on Wednesday, with institutional investors placing bids worth over Rs 5,650 crore. Institutional investors put in bids for over 22.07 crore shares at an indicative price of Rs 256.07 a share, as against over 9.40 crore shares on offer. The base issue size was over-subscribed 2 times, with bids worth Rs 5,650 crore coming in. The government is disinvesting 3 per cent equity in BHEL with an additional 2 per cent as a green-shoe option at a floor price of Rs 254 in the two-day offer for sale. Retail investors will be able to place a price bid on Thursday. The base issue size comprises over 10.44 crore shares, or 3 per cent stake, in BHEL, plus a greenshoe option to sell over 6.96 crore shares or 2 per cent. The sale of total 17.41 crore shares, or 5 per cent stake, would fetch the government Rs 4,422 crore. The government holds 63.17 per cent in BHEL. Shares of BHEL touched a low of Rs 258.60 in ...
Coca-Cola has told investors that India will continue to drive long-term volume growth, as it ramps up investments in digital platforms, AI-led tools and market expansion
Reliance Consumer Products has acquired Southern Health Foods of Tamil Nadu, owner of the Manna brand, to strengthen its foods and staples portfolio in the health foods segment
IHH Healthcare and Fortis Healthcare have launched IHH Catalyst, a national platform to help execution-ready medtech and healthtech startups move from pilots to hospital adoption and scale
Britannia Industries reported a 16.9% rise in consolidated net profit for Q3FY26, aided by strong momentum in biscuits and adjacent categories amid a stable commodity environment
French drugmaker to commit €15 million annually to SPC development and exports for cardiometabolic and venous diseases
US-based private equity firm Carlyle will invest Rs 2,100 crore to acquire a majority stake in Edelweiss Group's housing finance arm Nido Home Finance, subject to regulatory approvals
The government will sell up to 5 per cent stake in Bharat Heavy Electricals Ltd (BHEL) via an offer for sale (OFS) beginning on Wednesday at a floor price of Rs 254 a share. "Government offers to disinvest 3 per cent equity in the BHEL with an additional 2 oer cent as green shoe option," Department of Investment and Public Asset Management (DIPAM) Secretary Arunish Chawla said on X. The issue will open for non-retail investors on Wednesday, while retail investors will get to put in price bid on Thursday. If fully subscribed at the floor price, sale of 17.41 crore shares, or 5 per cent stake, would fetch the government Rs 4,422 crore. The floor price of Rs 254 a share is about 8 per cent below BHEL's closing share price of Rs 276.05 on the BSE. The base issue size comprises over 10.44 crore shares, or 3 per cent stake, in BHEL, plus a greenshoe option to sell over 6.96 crore shares or 2 per cent. The government holds 63.17 per cent in BHEL. Shares of BHEL closed at Rs 276.05, up 0
Eicher Motors reported a 21 per cent rise in net profit in the December quarter, driven by strong Royal Enfield sales and improved performance at VE Commercial Vehicles
Jubilant FoodWorks posted a 65.2 per cent rise in consolidated net profit in Q3 FY26, aided by strong revenue growth, margin expansion and robust performance at Domino's and Popeyes
Cholamandalam Financial Holdings Ltd on Tuesday reported a 27 per cent rise in consolidated profit after tax to Rs 1,386 crore for the October-December 2025 quarter. The city-headquartered company, part of the diversified Murugappa Group, had posted a profit after tax of Rs 1,093 crore in the corresponding quarter of the previous financial year. Cholamandalam Financial Holdings Ltd (formerly TI Financial Holdings Ltd) has significant shareholdings in group companies, including Cholamandalam Investment and Finance Company Ltd, Cholamandalam MS General Insurance Company Ltd and Cholamandalam MS Risk Services Ltd. In a statement, the company said profit after tax for the nine-month period ended December 31, 2025, rose 14 per cent to Rs 3,860 crore, compared with Rs 3,378 crore in the same period a year ago. Total income for the OctoberDecember 2025 quarter increased 17 per cent to Rs 10,084 crore from Rs 8,593 crore in the year-ago period. For the nine-month period ended December 31,
Tata Motors Passenger Vehicles and JLR have begun operations at a Rs 9,000 crore plant in Panapakkam, positioning Tamil Nadu as a key node in Jaguar Land Rover's global manufacturing network
Tata Sons chairman N Chandrasekaran asked TCS employees to embed AI into daily work, reflect on recent underperformance and focus on execution as adoption of the technology accelerates
Leading stock exchange BSE on Monday reported a nearly three times jump in consolidated profit to Rs 602 crore for the December quarter, driven by strong growth in equity derivatives trading, listings and mutual fund transactions. The exchange posted a profit of Rs 220 crore in the corresponding period of the last fiscal year. Total revenue for the quarter under review stood at an all-time high of Rs 1,334 crore, up 61 per cent from Rs 829 crore a year earlier, BSE said in a statement. This also marks the exchange's 11th consecutive record performance. Further, operating expenses declined 4 per cent year-on-year to Rs 512 crore, further boosting profitability. Investment and other income increased 47 per cent to Rs 90 crore during the quarter. Commenting on the results, BSE MD and CEO Sundararaman Ramamurthy said the exchange's "strong Q3 performance is a testament to the strength of our platforms and the confidence the marketplaces in BSE". "With record SME listings, growing ind
The Ramco Cements Ltd on Monday reported an over two-fold jump year-on-year in its consolidated net profit at Rs 385.63 crore in the December quarter of FY26, helped by improvement in cement prices and operational efficiencies. The company posted a net profit of Rs 181.58 crore during the October-December quarter of the previous fiscal, according to a regulatory filing by The Ramco Cements. Revenue from operations was up 6.16 per cent to Rs 2,105.68 crore in the December quarter of FY26. It was at Rs 1,983.45 crore in the corresponding period of the previous fiscal. "During Q3 FY26, the cement sale volume is 4.43 million tonnes, compared to 4.28 million tonnes in Q3 FY25 with a growth of 4 per cent," the company said in its earnings statement. The construction chemical business registered a sale volume of 1.54 lakh tonnes for Q3FY26 as against 0.86 lakh tonnes during Q3FY25, registering a growth of 79 per cent. "The overall sale volume for the current quarter has increased by 5 pe
The FMCG major will acquire a 75% stake in Vietnam-based Skinetiq in an all-cash deal valued at Rs 350 crore, strengthening its premium beauty and D2C play in the market
Leading shoemaker Bata India Ltd on Monday reported a 12.61 per cent rise in consolidated net profit to Rs 66.1 crore in the December quarter of FY'26 compared to the year-ago period. It had posted a net profit of Rs 58.7 crore in the previous October-December a year ago, according to a regulatory filing from Bata India. Bata's revenue from operations was up 2.81 per cent to Rs 944.68 crore during the quarter under review compared to Rs 918.79 crore in the corresponding quarter a year ago. Its total expenses in the December quarter were at Rs 868.92 crore, up 3.3 per cent on a year-on-year basis. Bata India's total income, which includes other income, was up 3.93 per cent to Rs 965.72 crore. Shares of Bata India Ltd on Monday settled at Rs 884.35 apiece on BSE, up 4.27 per cent.
Aurobindo Pharma on Monday said its consolidated net profit increased 8 per cent year-on-year to Rs 910 crore for the December quarter, led by robust sales in Europe and the US. The Hyderabad-based drug major reported a net profit of Rs 846 crore for the October-December period of the last fiscal year. Total revenue from operations increased to Rs 8,646 crore during the quarter as compared with Rs 7,979 crore in the year-ago period, the drug firm said in a statement. "Q3 reflected steady execution across Aurobindo's core businesses, supported by stable demand and the strength of our diversified product portfolio in key markets, including the US and Europe," Aurobindo Pharma Vice-Chairman and MD K Nithyananda Reddy said. Growth remained measured, with continued focus on operational discipline and a balanced approach to growth and profitability, he added. "As we progress our strategic initiatives, we remain cautious yet confident in our ability to support sustainable value creation